Authors :
Dr. Rohit Sane; Dr. Gurudatta Amin; Dr. Pravin Ghadigaonkar; Dr. Nilesh Kulthe; Dr. Shivali Sarmalkar; Dr. Trupti Waghmare
Volume/Issue :
Volume 11 - 2026, Issue 5 - May
Google Scholar :
https://tinyurl.com/495zmupx
Scribd :
https://tinyurl.com/2dudrap4
DOI :
https://doi.org/10.38124/ijisrt/26May1613
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
Background:
Mumbai-Mulund West's DM Package cohort is characterised by older age (mean 56.1 years), higher baseline blood
pressure (SBP 146 mmHg), and complex comorbidities including CHF, dyslipidaemia, and multi-organ involvement. This
cohort tests the protocol's efficacy at the challenging end of the cardiometabolic spectrum.
Objective:
To evaluate the effect of the Madhavbaug CDC Panchakarma-based multimodal protocol on glycaemic,
anthropometric, cardiometabolic, and medication parameters exclusively in DM Package patients (n=26) at the Mumbai
(Mulund-West) Central RIC clinic.
Methods:
Retrospective observational study. 26 T2DM patients enrolled in the DM Package at Mumbai (Mulund-West) Central
RIC. Only DM Package care plans (CDC-SP Base/1/2/3, CDC-KP Base/1/2/3, DM-HTN 1/2/3) included. Paired Student's ttest (two-tailed) for within-group pre–post comparisons (p<0.05 significant). Descriptive statistics as mean ± SD.
Keywords :
Mulund Mumbai, HbA1c, RBS, SBP, DBP, Heart Rate, Older Diabetics, CDC Protocol, Ayurveda, Cardiometabolic, CHF Comorbidity.
References :
- International Diabetes Federation (IDF). Diabetes Atlas, 10th Edition. Brussels: IDF; 2021.
- Mohan V, et al. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125(3):217–230.
- Charaka Samhita, Chikitsa Sthana, Prameha Chikitsa, Chapter 6. Varanasi: Chaukhamba Sanskrit Pratishthan.
- Sushruta Samhita, Nidana Sthana, Prameha Nidana. Varanasi: Krishnadas Academy.
- Shanmugasundaram ER, et al. Possible regeneration of the islets of Langerhans in streptozotocin-diabetic rats given Gymnema sylvestre leaf extracts. J Ethnopharmacol. 1990;30(3):265–279.
- Singh J, et al. Berberis aristata: A review. Phytother Res. 2003;17(5):439–444.
- Lean ME, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541–551.
- American Diabetes Association. Standards of Medical Care in Diabetes – 2024. Diabetes Care. 2024;47(Suppl 1).
- Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13–e115.
- Patwardhan B, et al. Ayurveda and natural products drug discovery. Curr Sci. 2004;86(6):789–799.
Background:
Mumbai-Mulund West's DM Package cohort is characterised by older age (mean 56.1 years), higher baseline blood
pressure (SBP 146 mmHg), and complex comorbidities including CHF, dyslipidaemia, and multi-organ involvement. This
cohort tests the protocol's efficacy at the challenging end of the cardiometabolic spectrum.
Objective:
To evaluate the effect of the Madhavbaug CDC Panchakarma-based multimodal protocol on glycaemic,
anthropometric, cardiometabolic, and medication parameters exclusively in DM Package patients (n=26) at the Mumbai
(Mulund-West) Central RIC clinic.
Methods:
Retrospective observational study. 26 T2DM patients enrolled in the DM Package at Mumbai (Mulund-West) Central
RIC. Only DM Package care plans (CDC-SP Base/1/2/3, CDC-KP Base/1/2/3, DM-HTN 1/2/3) included. Paired Student's ttest (two-tailed) for within-group pre–post comparisons (p<0.05 significant). Descriptive statistics as mean ± SD.
Keywords :
Mulund Mumbai, HbA1c, RBS, SBP, DBP, Heart Rate, Older Diabetics, CDC Protocol, Ayurveda, Cardiometabolic, CHF Comorbidity.